Maravai LifeSciences Holdings Inc expected to post a loss of 7 cents a share - Earnings Preview

Maravai Lifesciences Holdings

10/05/2025 24:44

Maravai LifeSciences Holdings Inc MRVI.OQ MRVI.O is expected to show a fall in quarterly revenue when it reports  results on May 12 for the period ending March 31 2025

The San Diego California-based  company is expected to report a 31.4% decrease in revenue to $44.009 million from $64.18 million a year ago, according to the mean estimate from 13 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Maravai LifeSciences Holdings Inc is for a loss of 7 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Maravai LifeSciences Holdings Inc is $5.00​, above​ its last closing price of $1.98. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.04
-0.04
-0.06
Missed
-50
Sep. 30 2024
-0.01
-0.01
-0.02
Missed
-160.1
Jun. 30 2024
0.00
0.00
0.00
Met
-100​
Mar. 31 2024
-0.03
-0.03
-0.02
Beat
21.4
​​Dec. 31 2023
-0.01
-0.01
0.01
Beat
184.6
Sep. 30 2023
0.00
0.01
-0.01
Missed
-257.2​
Jun. 30 2023
0.01
0.01
0.00
Missed
-100
Mar. 31 2023
0.04
0.04
0.03
Missed
-17.2

This summary was machine generated May 9 at 23:44 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)